(VIANEWS) – Krystal Biotech (KRYS), Novanta (NOVT), CrossFirst Bankshares (CFB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Krystal Biotech (KRYS)
127.5% sales growth and 14.2% return on equity
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Krystal Biotech has a trailing twelve months EPS of $3.95.
PE Ratio
Krystal Biotech has a trailing twelve months price to earnings ratio of 45.24. Meaning, the purchaser of the share is investing $45.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.2%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 66.3% and positive 220% for the next.
Sales Growth
Krystal Biotech’s sales growth is 883.8% for the present quarter and 127.5% for the next.
Volume
Today’s last reported volume for Krystal Biotech is 209790 which is 15.62% below its average volume of 248637.
2. Novanta (NOVT)
24.8% sales growth and 9.36% return on equity
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Earnings Per Share
As for profitability, Novanta has a trailing twelve months EPS of $1.72.
PE Ratio
Novanta has a trailing twelve months price to earnings ratio of 102.1. Meaning, the purchaser of the share is investing $102.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.36%.
Volume
Today’s last reported volume for Novanta is 10070 which is 93.47% below its average volume of 154340.
Yearly Top and Bottom Value
Novanta’s stock is valued at $175.61 at 06:22 EST, below its 52-week high of $187.12 and way higher than its 52-week low of $111.20.
Sales Growth
Novanta’s sales growth is 8.6% for the current quarter and 24.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 899.85M for the twelve trailing months.
3. CrossFirst Bankshares (CFB)
8.5% sales growth and 10.35% return on equity
CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and land development, 1-4 family real estate, multifamily real estate, commercial and industrial, energy, and consumer loans. It also provides a range of deposit products consisting of non-interest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. It has full-service banking offices in Kansas, Missouri, Oklahoma, Arizona, Colorado, New Mexico, and Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.
Earnings Per Share
As for profitability, CrossFirst Bankshares has a trailing twelve months EPS of $1.42.
PE Ratio
CrossFirst Bankshares has a trailing twelve months price to earnings ratio of 11.39. Meaning, the purchaser of the share is investing $11.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.35%.
4. Hexcel Corporation (HXL)
7.6% sales growth and 6.61% return on equity
Hexcel Corporation, together with its subsidiaries, develops, manufactures, and markets structural materials for use in commercial aerospace, space and defense, and industrial markets. It operates through two segments, Composite Materials and Engineered Products. The Composite Materials segment manufactures and markets carbon fibers, fabrics and specialty reinforcements, prepregs and other fiber-reinforced matrix materials, structural adhesives, honeycomb, molding compounds, tooling materials, polyurethane systems, and laminates that are used in military and commercial aircraft, wind turbine blades, recreational products, and other industrial applications, as well as in automotive, marine, and trains. The Engineered Products segment manufactures and markets aircraft structures and finished aircraft components, including wing to body fairings, wing panels, flight deck panels, door liners, rotorcraft blades, spars, and tip caps; and aircraft structural sub-components and semi-finished components used in rotorcraft blades, engine nacelles, and aircraft surfaces, such as flaps, wings, elevators, and fairings. The company sells its products directly through its managers, product managers, and sales personnel, as well as through independent distributors and manufacturer representatives in the Americas, Europe, the Asia Pacific, India, and Africa. Hexcel Corporation was founded in 1946 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Hexcel Corporation has a trailing twelve months EPS of $1.27.
PE Ratio
Hexcel Corporation has a trailing twelve months price to earnings ratio of 49.39. Meaning, the purchaser of the share is investing $49.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.61%.
Sales Growth
Hexcel Corporation’s sales growth is 6.9% for the current quarter and 7.6% for the next.
5. Elbit Systems Ltd. (ESLT)
5.3% sales growth and 8.37% return on equity
Elbit Systems Ltd. develops and supplies a portfolio of airborne, land, and naval systems and products for the defense, homeland security, and commercial aviation applications primarily in Israel, North America, the Asia-Pacific, Europe, Latin America, and internationally. The company operates through five segments: Aerospace; C4I and Cyber; Intelligence, Surveillance, Target Acquisition and Reconnaissance (ISTAR) and Electronic Warfare (EW); Land; and Elbit Systems of America (ESA). It also offers military aircraft and helicopter systems; commercial aviation systems and aerostructures; unmanned aircraft systems; flight academy solutions, electro-optic, night vision, high power energy solutions, and countermeasures systems; naval systems; land vehicle systems; munitions, such as precision munitions for land, air, and sea applications; command, control, communications, computer, intelligence, surveillance and reconnaissance, and cyber systems; electronic warfare and signal intelligence systems; and other commercial activities. In addition, the company manufactures and sells data links and radio communication systems and equipment, and cyber intelligence, autonomous, and homeland security solutions. Further, it provides various electronic warfare and signal intelligence systems, and laser systems; armored vehicle and other platforms survivability and protection systems, artillery, and mortar systems, as well as provides various training and support services. Additionally, the company offers products and systems solutions to military, foreign military sales, homeland security, medical instrumentation, and commercial aviation clients. It markets its systems and products as a prime contractor or subcontractor to various governments and companies. The company was incorporated in 1966 and is based in Haifa, Israel.
Earnings Per Share
As for profitability, Elbit Systems Ltd. has a trailing twelve months EPS of $5.43.
PE Ratio
Elbit Systems Ltd. has a trailing twelve months price to earnings ratio of 37.19. Meaning, the purchaser of the share is investing $37.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.37%.
Volume
Today’s last reported volume for Elbit Systems Ltd. is 13442 which is 40.8% below its average volume of 22707.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 6.31B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 15, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 0.99%.
